Rb2/p130 Expression in Breast and Endometrial Cancer
Author Information
Author(s): Milde-Langosch K, Goemann C, Methner C, Rieck G, Bamberger A-M, Löning T
Primary Institution: University Hospital Eppendorf, Hamburg, Germany
Hypothesis
The study investigates the role of Rb2/p130 protein expression in breast and endometrial cancers and its correlation with hormone receptor status.
Conclusion
Loss of Rb2 expression may be linked to the development and dedifferentiation of endometrial and some breast cancers.
Supporting Evidence
- Weak or absent Rb2 expression was found in 59% of endometrial carcinomas compared to 24% in mammary carcinomas.
- Significant positive correlations were found between Rb2 expression and Rb, ER, and PR-B in breast cancer samples.
- Rb2 mRNA expression correlated significantly with Western blot results in 56 tissue samples.
Takeaway
The study looked at a protein called Rb2 in breast and endometrial cancers and found that lower levels of this protein might be related to how these cancers grow.
Methodology
Western blot experiments and semi-quantitative RT-PCR were performed on tumor and normal tissue samples.
Participant Demographics
68 mammary carcinomas and 41 endometrial carcinomas were studied.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website